Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe: SECOND EDITION

Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe
SECOND EDITION

The essential reference for prescribing medical cannabis safely and effectively in Europe.

Co-authored by Cannabiscientia SA and Prohibition Partners

In recent years, many European countries have legalized or regulated Medical Cannabis, yet healthcare professionals and patients still face a significant knowledge gap regarding its therapeutic use, pharmacology, and legal frameworks.

Principles of Clinical Cannabinology – Second Edition bridges that gap — offering a science-based, clinically oriented, and regulation-aware overview of cannabinoid medicine across Europe.

• 600+ pages and 800+ scientific references

• 30+ pathologies reviewed through scientific and clinical evidence

• Legislative and product insights curated by Prohibition Partners Analysts

• Country-by-country overview for EU nations, the UK, and Switzerland, detailing:

  • Prescription pathways

  • Authorized prescribers

  • Insurance and reimbursement protocols

  • Available products and pharmacy retail prices

Developed by an international team of clinicians, researchers, and educators, this handbook serves as a practical guide and academic reference for physicians, pharmacists, nurses, and allied health professionals seeking to expand their expertise in cannabinoid medicine.

Part I – The Endocannabinoid System (ECS)
Explores the body’s intrinsic network for maintaining homeostasis, the role of endocannabinoids, and how cannabis derivatives modulate these pathways to produce therapeutic effects.

Part II – Pharmacology of Cannabis Sativa L.
Analyzes THC, CBD, minor cannabinoids, terpenes, and flavonoids, linking biochemical function to clinical relevance.

Part III – Clinical Evidence and Case Studies
Summarizes the latest global research and includes practical insights from experienced prescribers worldwide, supporting evidence-based treatment and patient care.

Part IV – European Legislation and Market Overview
Covers 24 countries, comparing public vs. private systems, regulatory frameworks, products availability and evolving access models. Updated regularly to reflect policy and market shifts.

Neurological & Neurodegenerative: Parkinson’s, Alzheimer’s, Epilepsy, Multiple Sclerosis
Musculoskeletal: Orthopedic pain, Muscular dystrophy, Low back pain
Cardiovascular: Hypertension, Ischemia, Glaucoma
Metabolic & Palliative: Diabetes, Obesity, Glioblastoma, Spinal Cord Injury
Neuropsychiatric: PTSD, Autism, Migraine, Fibromyalgia, Sleep disorders
Gastrointestinal: IBS, IBD, Gastroparesis, Gastritis
Dermatological: Psoriasis, Eczema
Drug Interactions & Antibiotic Resistance

Each edition of Principles of Clinical Cannabinology evolves with:

• New countries and regulations

• Updated case studies and research

• Insights on emerging formulations and products

By integrating clinical experience, scientific rigor, and regulatory insight, this book empowers healthcare professionals to navigate the complex intersection of medicine, science, supply chain and policy, offering practical guidance for safe and effective cannabinoid therapy.

Ad Maiora.